Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
N/A
EC/CAS
108-88-3
Name of the chemical
Toluene
Concentration
50 ppm
General Information
Revision date
2004-08-10
Product name
Champagne Noble
Manufacturer Name
CUSTOMER IDENTIFICATION
Emergency telephone
800-424-9300, 703-527-3887
Icons in SDS
Company Information
company name
RAABE CORPORATION
Section 2
SECTION 2: Hazards identification
RAABE CORPORATION NG? WI470) Anincry Avenue Manomonee Fats, 1 53051-1430 RO. Box 090 Menomonee Fails, Wi 63052-1090 B00 946 7680 | 262 255 7800 | toc 262 255 06H4 Wa FOCDECoR.COT 3 EMERGENCY OVERVIEW: May be fatal if swallowed. Harmful if inhaled. Harmful if absorbed through skin. Causes eye irritation. Causes skin irritation. Vapors irritating to eyes and respiratory tract. Flammable liquid and vapor. Vapors may cause flash fire or explosion. EYE: May cause eye burns. SKIN: May cause skin irritation. Prolonged contact with the skin can cause chemical burns. Harmful if absorbed through the skin. Skin contact may aggravate an existing dermatitis. INHALATION: Exposure to high concentrations of vapors may cause dizziness, breathing difficulty, headaches or respiratory irritation. Extremely high concentrations may cause drowsiness, staggering, confusion, unconsciousness, coma or death. Excessive inhalation of vapors can cause nasal and respiratory irritation. Liquid or vapor may be irritating to skin, eyes, throat or lungs. Intentional misuse by deliberately concentrating and inhaling
Contains
of this product can be harmful or fatal. . Respiratory symptoms associated with pre-existing lung disorders may be aggravated by exposure to material(s) is this product. INGESTION: Moderately toxic. May cause stomach discomfort, nausea, vomiting, diarrhea, and narcosis. Aspiration of material into the lungs if swallowed or if vomiting occurs can cause chemical pneumonitis which can be fatal. May cause nausea, vomiting and diarrhea.
Potential chronic health
. Chronic overexposure to a component or components in this material has been found to cause the following effects in laboratory animals: Kidney damage Eye damage Blood damage Lung damage Liver damage Spleen damage Anemia Brain damage RAABE CORPORATION NG? W470) Anthony Avenue Menomonee Fak, Wi 63061-1630 RO, Box 1070 Manomcnee Fails, Wi 63052-1090 800 966 7580 | 262 256 500 | tox 262 265 0604 we rocbeccp, Con == 4 20555 668457 .6B Reproductive system damage Chronic overexposure to a component or components is this product has been suggested as a cause of the following effects in humans: Liver damage Cardiac abnormalities Reports have associated repeated and prolonged overexposure to solvents with permanent brain and nervous system damage. Repeated breathing or skin contact of methyl ethyl ketone may increase the potency of neurotoxins such as hexane if exposures occur at the same time. Central nervous system depression, shock, coma, visual disturbances, and death. Onset of symptoms may be delayed as long as 30 hours. Rats exposed to titanium dioxide dust at 250 mg/m3 developed lung cancer, however, such exposure levels are not attainable in the workplace with this material. 2-Butoxyethanol causes harm to the fetus in laboratory animal studies. Harm to the fetus occurs only at exposure levels that harm the pregnant animal. The relevance of these findings to humans is uncertain. There is evidence that repeated long-term exposure to vapor concentrations greater than 50 ppm of n-butyl alcohol may result in some hearing loss. Product contains toluene which may be harmful to the fetus based on animal studies. Repeated exposure to toluene has been associated with high frequency hearing loss in laboratory animals. The human consequences of this finding is uncertain. In February 2000 the International Agency for Research on Cancer (TARC) classified ethylbenzene as possibly carcinogenic to humans (Group 2B} on the basis of sufficient evidence for carcinogenicity in experimental animals but inadequate evidence for cancer in humans. SECTION